ABERNETHY MATT bought NBIX
May 14, 2024 · Form 4 insider transaction
ABERNETHY MATT bought 15,000 shares of Neurocrine Biosciences, Inc. at $73.60 per share, a transaction worth $1.10M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$73.60
Total value
$1.10M
InsiderABERNETHY MATT
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 14, 2024
Filing dateMay 16, 2024
Shares owned after46,528
OwnershipDirect
10b5-1 planNo
AmendedNo